Bill Collier: Okay. Thanks, Karen. So, Mike, on the coronavirus approach.
Michael Sofia: Sure. So, I try to see it. So I think, when you look at the coronavirus space, when you talk to the sort of KOLs, there’s still a significant medical need for effective therapies, which to a large extent are lacking out there. As you probably heard, we were potentially seeing a surge here and, a surge in coronavirus SARS-CoV-2 diagnosis in the recent, recent news. So obviously pointing to the need still for therapeutics. In our strategy, it’s always been, I think, differentiated from others with the idea of a combination of two direct actinovirals, the MPro as well as the nsp12 polymerase inhibitor, to provide really a significantly potent therapeutic regimen that we believe could have impact on not only, existing infection in the patient but also maybe in pre- and post-exposure prophylaxis.
And finally, this whole issue of long COVID, that’s still a concern out there and how do you treat long COVID. And some of the theories are that, there’s some kind of reservoir of virus out there and if you can hit the virus very hard with effective therapeutics, you could possibly address long COVID. Still, we believe that there’s, a value in a COVID program right now. There are a number of key important unmet medical needs in the space that we think we can address with the strategy that we’ve also met.
Unidentified Analyst: Great. Thank you so much for giving that additional color and I appreciate your time today.
Bill Collier: Thank you.
Operator: Thank you. I will now turn it back over to management for closing remarks.
Bill Collier: All right. And I’d just like to take a moment to thank everyone for joining us this morning. We do appreciate your continued interest and support of Arbutus and we look forward to providing you the updates as we progress the development of our HPV and coronavirus assets this year. So thank you, everybody. Operator, that concludes our call.
Operator: Thank you. Thank you for your participation in today’s conference. This does conclude the program. You may now disconnect.